Clinical Trial Update: Phase II FANG™ in Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase II study of FANG in advanced melanoma was terminated, with results posted in May 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• FANG

Snippet

Sponsor: Gradalis, Inc. | Conditions: Advanced Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2018-05-11